UV Clinical A/S: Financial statements 2019
CVR: 38401572
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
UV Clinical A/S (CVR 38401572) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -576,665 and a net result of DKK -1,433,657 compared with DKK -798,697 the year before. Equity in the 2019 report amounted to DKK -975,213. The company had 1 employee in the financial year.
- Gross Profit
- DKK -576,665
- Profit/Loss
- DKK -1,433,657
- Equity
- DKK -975,213
- Total Assets
- DKK 1,212,978
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -577K | -1.4M | -975K | 1 |
| 2018 | - | 4K | -799K | -584K | 1 |
| 2017 | - | -376K | -1.1M | 215K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of November 1, 2019, Brian Schebye has joined the board of directors of UV Clinical A/S.
UV Clinical A/S has published its annual report for 2018. Gross profit came to DKK 3,701, and the net result was DKK -798,697.
About UV Clinical A/S
UV Clinical A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named UV Clinical ApS. The management consists of Rolf Henrik Sprunk-Jansen. The board consists of Helge Holm-Larsen (chair), Emilio de la Guardia Gascuñana and Rolf Henrik Sprunk-Jansen. The company is owned by Ulstrup Invest ApS, Canajo Invest ApS and Holafa ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 1,274,253 and a net result of DKK -1,282,165 compared with DKK -1,895,100 the year before. Equity in the 2025 report amounted to DKK 22,796,335.